Results 271 to 280 of about 243,841 (348)

Identification and Validation of Biomarkers in Chronic Rhinosinusitis With Nasal Polyps and Study of Their Associated Mechanisms

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Background Cell senescence (CS) and lipid metabolism (LM) disorders have been reported in chronic rhinosinusitis with nasal polyps (CRSwNP). However, the mechanism is still unclear. Methods Data were obtained from public databases; differential expression analysis and machine learning were performed to identify biomarkers and to understand the
Hui‐Yi Deng   +3 more
wiley   +1 more source

Research Progress on Upper Airway Cough Syndrome

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Upper airway cough syndrome (UACS) has been identified as a significant contributor to chronic cough in various national guidelines. However, the complexity of its pathogenesis, the lack of clarity surrounding its diagnostic criteria, and its overlap with other etiologies of chronic cough present considerable challenges in both diagnosis and ...
Wan‐Ting Huang, Jia Chen
wiley   +1 more source

Correction to: The role of purinergic P2X3 receptors and endometriosis-associated hyperalgesia. [PDF]

open access: yesPurinergic Signal
Pretto KP   +7 more
europepmc   +1 more source

Preoperative Periapical Status and Outcomes of Vital Pulp Therapy: A Systematic Review and Meta‐Analysis

open access: yesAustralian Endodontic Journal, EarlyView.
ABSTRACT This systematic review has investigated whether the preoperative periapical radiographic status (PPRS) is a predictor of VPT success/survival. Four databases were searched for studies published from inception to November 2024. The studies' characteristics were tabulated, and a meta‐analysis was performed to evaluate the correlation between ...
Isadora de Souza Basso   +3 more
wiley   +1 more source

Demographic Factors Influencing Eligibility for EMA in South Australia

open access: yesAustralian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background Early medical abortion (EMA) can be performed by administration of mifepristone and misoprostol in an outpatient setting prior to 63 days gestation in Australia. While this is a flexible, efficacious and safe option for abortion, it requires early identification of pregnancy and efficient access to a clinical service. Outpatient EMA
Laura Slade   +3 more
wiley   +1 more source

The Sociodemographic Benefits of Extending MS‐2Step to 70 Days in Australia

open access: yesAustralian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT In many areas of the world, outpatient early medical abortion (EMA) is provided through mifepristone and misoprostol up to 10 weeks or 70 days gestation; however in Australia access is restricted to 63 days. A retrospective cohort study using South Australian data from 2012 to 2020 compares women undergoing abortion at less than 9 weeks with ...
Laura Slade   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy